ACTINIUM PHARMACEUTICALS INC ATNM
ASignal's systematic analysis rates ATNM as Bullish.
Reflects the latest available analysis · analyzed Nov 6, 2026
The case on ATNM
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong profitability with 100% gross margin and 78.76% operating margin
- Exceptional return on equity (45.86%) indicating high capital efficiency
- Low debt-to-equity ratio (0.04x) signaling strong financial health
- High cash position ($36.47M) relative to market cap and debt
- Current price above 20-day and 50-day moving averages suggesting positive momentum
- Negative MACD histogram indicating weakening bullish momentum
- Limited news coverage with only one source (Yahoo) and no Reddit sentiment data
- Negative operating cash flow ($-22.66M) despite positive free cash flow
- Lack of available revenue and earnings growth data (N/A) limiting growth visibility
See the full verdict on ATNM
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes ATNM
Most investors never get a second opinion, let alone several. ASignal runs ATNM past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.